179 related articles for article (PubMed ID: 15206130)
21. [Educational program in the Medical Science Course, Kitasato University School of Allied Health Sciences].
Kitasato H; Takahashi S; Ohbu M; Obata F; Ogawa Z; Sato Y; Hattori M; Saito-Taki T; Hara K; Okano T; Kubo M; Maruyama H; Tsuchiya B; Okazaki T; Ishii N; Nishimura Y; Takada N; Abe M; Hachimura K; Tanigawa K; Katagiri M
Rinsho Byori; 2008 Jul; 56(7):606-11. PubMed ID: 18709993
[TBL] [Abstract][Full Text] [Related]
22. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
Zon R; Meropol NJ; Catalano RB; Schilsky RL
J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
[TBL] [Abstract][Full Text] [Related]
23. Regulatory aspects of cellular therapy product in Europe: JACIE accreditation in a processing facility.
Caunday O; Bensoussan D; Decot V; Bordigoni P; Stoltz JF
Biomed Mater Eng; 2009; 19(4-5):373-9. PubMed ID: 20042804
[TBL] [Abstract][Full Text] [Related]
24. Quality control system to support comparability assessment for the Renal Bio-Replacement therapy system.
Pitkin Z
Dev Biol (Basel); 2005; 122():131-8. PubMed ID: 16375257
[TBL] [Abstract][Full Text] [Related]
25. Clinical grade cell manipulation.
Giordano R; Lazzari L; Rebulla P
Vox Sang; 2004 Aug; 87(2):65-72. PubMed ID: 15355496
[TBL] [Abstract][Full Text] [Related]
26. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
[TBL] [Abstract][Full Text] [Related]
27. [Education concerning pathological/cytological diagnosis at 4-year colleges].
Fukuda T; Yoshida T
Rinsho Byori; 2007 Jun; 55(6):568-73. PubMed ID: 17657992
[TBL] [Abstract][Full Text] [Related]
28. [Unique system for education of medical technology and cytotechnology students at Kurashiki University of Science and the Arts].
Ohno E; Sakaguchi T; Miyake Y; Ohno S; Yakushiji H; Miyamoto T
Rinsho Byori; 2006 Mar; 54(3):286-91. PubMed ID: 16637578
[TBL] [Abstract][Full Text] [Related]
29. Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH).
Kern P
Parasitol Int; 2006; 55 Suppl():S273-82. PubMed ID: 16338164
[TBL] [Abstract][Full Text] [Related]
30. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
31. Will regulation be the death of cell therapy in the United States?
Gastineau DA
Bone Marrow Transplant; 2004 Apr; 33(8):777-80. PubMed ID: 14968138
[TBL] [Abstract][Full Text] [Related]
32. [Impact of regulations on translational research in cell and gene therapy: the American experience].
Rousseau RF; Gee AP
Bull Cancer; 2004 Mar; 91(3):239-47. PubMed ID: 15171048
[TBL] [Abstract][Full Text] [Related]
33. [Education and research toward the development of clinical laboratory techniques].
Shiba K
Rinsho Byori; 2004 May; 52(5):422-5. PubMed ID: 15206128
[TBL] [Abstract][Full Text] [Related]
34. Integration of the CLS doctorate into the healthcare organization.
Montoya I; Kimball O
Clin Lab Sci; 2009; 22(3):136-40. PubMed ID: 19827406
[TBL] [Abstract][Full Text] [Related]
35. Clinical laboratory sciences curriculum redevelopment: an application of change theories.
Mundt L; Vanik J
Clin Lab Sci; 2007; 20(2):72-9. PubMed ID: 17557705
[TBL] [Abstract][Full Text] [Related]
36. The doctorate in clinical laboratory science: enhanced quality for healthcare.
Leibach EK
Clin Lab Sci; 2008; 21(1):5-6. PubMed ID: 18335853
[No Abstract] [Full Text] [Related]
37. [Integrative medicine in health science education].
Koike H; Murakami H
Rinsho Byori; 2006 Mar; 54(3):292-4. PubMed ID: 16637579
[TBL] [Abstract][Full Text] [Related]
38. Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials.
Lewis RM; Gordon DJ; Poole-Wilson PA; Borer JS; Zannad F
Cardiology; 2008; 110(2):73-80. PubMed ID: 17975310
[TBL] [Abstract][Full Text] [Related]
39. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs.
Abou-El-Enein M; Römhild A; Kaiser D; Beier C; Bauer G; Volk HD; Reinke P
Cytotherapy; 2013 Mar; 15(3):362-83. PubMed ID: 23579061
[TBL] [Abstract][Full Text] [Related]
40. Clinical trials of GMP products in the gene therapy field.
Bamford KB
Methods Mol Biol; 2011; 737():425-42. PubMed ID: 21590408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
